Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus

Journal of Chemical Information and Modeling

Volumn 54, Issue 4, 2014, Pages 1208-1217

  Meeprasert, Arthitaya ^a   Hannongbua, Supot ^a   Rungrotmongkol, Thanyada ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISEASES; FREE ENERGY; HYDROGEN BONDS; MOLECULAR DYNAMICS; PATHOLOGY; REACTION KINETICS; VAN DER WAALS FORCES; VIRUSES;

BINDING FREE ENERGY; ENERGY DECOMPOSITION; HYDROGEN BOND PATTERNS; INFECTIOUS DISEASE; MOLECULAR DYNAMICS SIMULATIONS; RELATIVE BINDING AFFINITY; SERINE PROTEASE INHIBITOR; VAN DER WAALS INTERACTIONS;

BINDING ENERGY;

ANTIVIRUS AGENT; NS3 PROTEIN, HEPATITIS C VIRUS; NS4A PROTEIN, FLAVIVIRUS; PROTEIN BINDING; SERINE PROTEINASE INHIBITOR; VIRUS PROTEIN;

DRUG EFFECTS; HEPACIVIRUS; MOLECULAR DYNAMICS;

ANTIVIRAL AGENTS; HEPACIVIRUS; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; SERINE PROTEINASE INHIBITORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84899785133     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci400605a     Document Type: Article

References (50)

1. Lauer, G. M.; Walker, B. D. Hepatitis C Virus Infection N. Engl. J. Med. 2001, 345, 41-52
2. Bostan, N.; Mahmood, T. An Overview about Hepatitis C: A Devastating Virus Crit. Rev. Microbiol. 2010, 36, 91-133
3. Durantel, D.; Escuret, V.; Zoulim, F. Current and Emerging Therapeutic Approaches to Hepatitis C Infection Expert. Rev. Anti-Infect. Ther. 2003, 1, 441-454
4. Ferguson, M. C. Current Therapies for Chronic Hepatitis C Pharmacotherapy 2010, 31, 92-111
5. Fried, M. W.; Shiffman, M. L.; Reddy, K. R.; Smith, C.; Marinos, G.; Goncales, F. L., Jr.; Haussinger, D.; Diago, M.; Carosi, G.; Dhumeaux, D.; Craxi, A.; Lin, A.; Hoffman, J.; Yu, J. Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection N. Engl. J. Med. 2002, 347, 975-982
6. Yi, M.; Villanueva, R. A.; Thomas, D. L.; Wakita, T.; Lemon, S. M. Production of Infectious Genotype 1a Hepatitis C Virus (Hutchinson Strain) in Cultured Human Hepatoma Cells Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 2310-2315
7. Lagace, L.; White, P. W.; Bousquet, C.; Dansereau, N.; Do, F.; Llinas-Brunet, M.; Marquis, M.; Massariol, M. J.; Maurice, R.; Spickler, C.; Thibeault, D.; Triki, I.; Zhao, S.; Kukolj, G. In Vitro Resistance Profile of the Hepatitis C Virus NS3 Protease Inhibitor BI 201335 Antimicrob. Agents Chemother. 2012, 56, 569-572
8. Seiwert, S. D.; Andrews, S. W.; Jiang, Y.; Serebryany, V.; Tan, H.; Kossen, K.; Rajagopalan, P. T.; Misialek, S.; Stevens, S. K.; Stoycheva, A.; Hong, J.; Lim, S. R.; Qin, X.; Rieger, R.; Condroski, K. R.; Zhang, H.; Do, M. G.; Lemieux, C.; Hingorani, G. P.; Hartley, D. P.; Josey, J. A.; Pan, L.; Beigelman, L.; Blatt, L. M. Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227) Antimicrob. Agents Chemother. 2008, 52, 4432-4441
9. White, P. W.; Llinas-Brunet, M.; Amad, M.; Bethell, R. C.; Bolger, G.; Cordingley, M. G.; Duan, J.; Garneau, M.; Lagace, L.; Thibeault, D.; Kukolj, G. Preclinical Characterization of BI 201335, a C-terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease Antimicrob. Agents Chemother. 2010, 54, 4611-4618
10. da Cunha, E. F. F.; Ramalho, T. C.; Taft, C. A.; de Alencastro, R. B. Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with Wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease Lett. Drug Des. Discovery 2006, 3, 17-28
11. Ontoria, J. M.; Di Marco, S.; Conte, I.; Di Francesco, M. E.; Gardelli, C.; Koch, U.; Matassa, V. G.; Poma, M.; Steinkühler, C.; Volpari, C.; Harper, S. The Design and Enzyme-bound Crystal Structure of Indoline Based Peptidomimetic Inhibitors of Hepatitis C Virus NS3 Protease J. Med. Chem. 2004, 47, 6443-6446
12. Wei, H. Y.; Lu, C. S.; Lin, T. H. Exploring the P2 and P3 Ligand Binding Features for Hepatitis C Virus NS3 Protease Using Some 3D QSAR Techniques J. Mol. Graphics Modell. 2008, 26, 1131-1144
13. Xue, W.; Wang, M.; Jin, X.; Liu, H.; Yao, X. Understanding the Structural and Energetic Basis of Inhibitor and Substrate Bound to the Full-Length NS3/4A: Insights from Molecular Dynamics Simulation, Binding Free Energy Calculation and Network Analysis Mol. Biosyst. 2012, 8, 2753-2765
14. Lin, C. HCV NS3-4A Serine Protease. In Hepatitis C viruses: Genomes and molecular biology; Tan, S. L., Ed.; Horizon Bioscience: Norfolk, 2006; Chapter 6, pp 163-206.
15. Lin, K. Development of Novel Antiviral Therapies for Hepatitis C Virus Virol. Sin. 2010, 25, 246-266
16. Lindenbach, B. D.; Rice, C. M. Unravelling Hepatitis C Virus Replication from Genome to Function Nature 2005, 436, 933-938
17. Love, R. A.; Parge, H. E.; Wickersham, J. A.; Hostomsky, Z.; Habuka, N.; Moomaw, E. W.; Adachi, T.; Hostomska, Z. The Crystal Structure of Hepatitis C Virus NS3 Proteinase Reveals a Trypsin-like Fold and a Structural Zinc Binding Site Cell 1996, 87, 331-342
18. Lemke, C. T.; Goudreau, N.; Zhao, S.; Hucke, O.; Thibeault, D.; Llinas-Brunet, M.; White, P. W. Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Pepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335 J. Biol. Chem. 2011, 286, 11434-11443
19. Perni, R. B.; Chandorkar, G.; Cottrell, K. M.; Gates, C. A.; Lin, C.; Lin, K.; Luong, Y.-P.; Maxwell, J. P.; Murcko, M. A.; Pitlik, J.; Rao, G.; Schairer, W. C.; Drie, J. V.; Wei, Y. Inhibitors of Hepatitis C Virus NS3·4A Protease. Effect of P4 Capping Groups on Inhibitory Potency and Pharmacokinetics Bioorg. Med. Chem. Lett. 2007, 17, 3406-3411
20. Prongay, A. J.; Guo, Z.; Yao, N.; Pichardo, J.; Fischmann, T.; Strickland, C.; Myers, J.; Weber, P. C.; Beyer, B. M.; Ingram, R.; Hong, Z.; Prosise, W. W.; Ramanathan, L.; Taremi, S. S.; Yarosh-Tomaine, T.; Zhang, R.; Senior, M.; Yang, R.-S.; Malcolm, B.; Arasappan, A.; Bennett, F.; Bogen, S. L.; Chen, K.; Jao, E.; Liu, Y.-T.; Lovey, R. G.; Saksena, A. K.; Venkatraman, S.; Girijavallabhan, V.; Njoroge, F. G.; Madison, V. Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6, 6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key Steps in Structure-Based Optimization J. Med. Chem. 2007, 50, 2310-2318
21. Romano, K. P.; Ali, A.; Royer, W. E.; Schiffer, C. A. Drug Resistance Against HCV NS3/4A Inhibitors Is Defined by the Balance of Substrate Recognition versus Inhibitor Binding Proc. Natl. Acad. Sci. 2010, 107, 20986-20991
22. Xue, W.; Ban, Y.; Liu, H.; Yao, X. Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis J. Chem. Inf. Model. 2014, 54, 621-633
23. Romano, K. P.; Ali, A.; Aydin, C.; Soumana, D.; Özen, A.; Deveau, L. M.; Silver, C.; Cao, H.; Newton, A.; Petropoulos, C. J.; Huang, W.; Schiffer, C. A. The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors PLoS Pathog. 2012, 8, e1002832
24. Tong, L.; Wengler, G.; Rossmann, M. G. Refined Structure of Sindbis Virus Core Protein and Comparison with Other Chymotrypsin-like Serine Proteinase Structures J. Mol. Biol. 1993, 230, 228-247
25. De Francesco, R.; Steinkuhler, C. Structure and Function of the Hepatitis C Virus NS3-NS4A Serine Proteinase Curr. Top. Microbiol. Immunol. 2000, 242, 149-169
26. Frecer, V.; Kabelac, M.; De Nardi, P.; Pricl, S.; Miertus, S. Structure-Based Design of Inhibitors of NS3 Serine Protease of Hepatitis C Virus J. Mol. Graphics Modell. 2004, 22, 209-220
27. Gallinari, P.; Brennan, D.; Nardi, C.; Brunetti, M.; Tomei, L.; Steinkühler, C.; De Francesco, R. Multiple Enzymatic Activities Associated with Recombinant NS3 Protein of Hepatitis C Virus J. Virol. 1998, 72, 6758-6769
28. Johansson, A.; Hubatsch, I.; Akerblom, E.; Lindeberg, G.; Winiwarter, S.; Danielson, U. H.; Hallberg, A. Inhibition of Hepatitis C Virus NS3 Protease Activity by Product-Based Peptides is Dependent on Helicase Domain Bioorg. Med. Chem. Lett. 2001, 11, 203-206
29. Case, D. A.; Cheatham, T. E.; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The Amber Biomolecular Simulation Programs J. Comput. Chem. 2005, 26, 1668-1688
30. Olsson, M. H. M.; Søndergaard, C. R.; Rostkowski, M.; Jensen, J. H. PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions J. Chem. Theory Comput. 2011, 7, 525-537
31. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-Phase Quantum Mechanical Calculations J. Comput. Chem. 2003, 24, 1999-2012
32. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, Revision C.02; Gaussian, Inc.: Wallingford, CT, 2004.
33. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and Testing of a General Amber Force Field J. Comput. Chem. 2004, 25, 1157-1174
34. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water J. Chem. Phys. 1983, 79, 926-935
35. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. C. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes J. Comput. Phys. 1977, 23, 327-341
36. York, D. M.; Darden, T. A.; Pedersen, L. G. The Effect of Long-Range Electrostatic Interactions in Simulations of Macromolecular Crystals-a Comparison of the Ewald and Truncated List Methods J. Chem. Phys. 1993, 99, 8345-8348
37. Hou, T.; Wang, J.; Li, Y.; Wang, W. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations J. Chem. Inf. Model. 2011, 51, 69-82
38. Li, X.; Zhang, W.; Qiao, X.; Xu, X. Prediction of Binding for a Kind of Non-Peptic HCV NS3 Serine Protease Inhibitors from Plants by Molecular Docking and MM/PBSA Method Bioorg. Med. Chem. 2007, 15, 220-226
39. Kaiyawet, N.; Rungrotmongkol, T.; Hannongbua, S. Effect of Halogen Substitutions on dUMP to Stability of Thymidylate Synthase/dUMP/mTHF Ternary Complex Using Molecular Dynamics Simulation J. Chem. Inf. Model. 2013, 53, 1315-1323
40. Khuntawee, W.; Rungrotmongkol, T.; Hannongbua, S. Molecular Dynamic Behavior and Binding Affinity of Flavonoid Analogues to the Cyclin Dependent Kinase 6/Cyclin D Complex J. Chem. Inf. Model. 2012, 52, 76-83
41. Meeprasert, A.; Khuntawee, W.; Kamlungsua, K.; Nunthaboot, N.; Rungrotmongkol, T.; Hannongbua, S. Binding Pattern of the Long Acting Neuraminidase Inhibitor Laninamivir towards Influenza A Subtypes H5N1 and Pandemic H1N1 J. Mol. Graphics Modell. 2012, 38, 148-154
42. Rungrotmongkol, T.; Nunthaboot, N.; Malaisree, M.; Kaiyawet, N.; Yotmanee, P.; Meeprasert, A.; Hannongbua, S. Molecular Insight into the Specific Binding of ADP-Ribose to the nsP3Macro Domains of Chikungunya and Venezuelan Equine Encephalitis Viruses: Molecular Dynamics Simulations and Free Energy Calculations J. Mol. Graphics Modell. 2010, 29, 347-353
43. Gohlke, H.; Case, D. A. Converging Free Energy Estimates: MM-PB(GB)SA Studies on the Protein-Protein Complex Ras-Raf J. Comput. Chem. 2004, 25, 238-250
44. Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. E. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models Acc. Chem. Res. 2000, 33, 889-897
45. Li, X.; Zhang, Y. K.; Liu, Y.; Ding, C. Z.; Zhou, Y.; Li, Q.; Plattner, J. J.; Baker, S. J.; Zhang, S.; Kazmierski, W. M.; Wright, L. L.; Smith, G. K.; Grimes, R. M.; Crosby, R. M.; Creech, K. L.; Carballo, L. H.; Slater, M. J.; Jarvest, R. L.; Thommes, P.; Hubbard, J. A.; Convery, M. A.; Nassau, P. M.; McDowell, W.; Skarzynski, T. J.; Qian, X.; Fan, D.; Liao, L.; Ni, Z. J.; Pennicott, L. E.; Zou, W.; Wright, J. Novel Macrocyclic HCV NS3 Protease Inhibitors Derived from Alpha-Amino Cyclic Boronates Bioorg. Med. Chem. Lett. 2010, 20, 5695-5700
46. Xue, W.; Pan, D.; Yang, Y.; Liu, H.; Yao, X. Molecular Modeling Study on the Resistance Mechanism of HCV NS3/4A Serine Protease Mutants R155K, A156V and D168A to TMC435 Antiviral Res. 2012, 93, 126-137
47. Halfon, P.; Locarnini, S. Hepatitis C Virus Resistance to Protease Inhibitors J. Hepatol. 2011, 55, 192-206
48. He, Y.; King, M. S.; Kempf, D. J.; Lu, L.; Lim, H. B.; Krishnan, P.; Kati, W.; Middleton, T.; Molla, A. Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System Antimicrob. Agents Chemother. 2008, 52, 1101-1110
49. Lenz, O.; Verbinnen, T.; Lin, T.-I.; Vijgen, L.; Cummings, M. D.; Lindberg, J.; Berke, J. M.; Dehertogh, P.; Fransen, E.; Scholliers, A.; Vermeiren, K.; Ivens, T.; Raboisson, P.; Edlund, M.; Storm, S.; Vrang, L.; de Kock, H.; Fanning, G. C.; Simmen, K. A. In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Antimicrob. Agents Chemother. 2010, 54, 1878-1887
50. Meeprasert, A.; Rungrotmongkol, T.; Li, M. S.; Hannongbua, S. In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus Curr. Pharm. Des. 2014, 10.2174/13816128113199990632